Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...

In April, J&J completed the acquisition of Intra-Cellular Therapies, which develops neuroscience drugs to treat conditions ...

If this neuromorphic machine is real, it’s a milestone for neuroscience—and a test of what AI can and can’t replace.

Though healthcare stocks have been much more measured this year, there are bright spots there as well. The medical-device maker Medtronic (MDT) closed at its highest price since May 12, 2022, after ...

Agios reported mixed results from a Phase 3 study of its drug Pyrukynd in sickle cell, raising doubts about the drug's ...

Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...

President Sheinbaum is walking a tightrope between firmness and patience to dodge the US leader’s recurring proposal to send ...

Zentalis Pharmaceuticals, Inc. focuses on developing azenosertib with a pivotal Denali Phase 2 trial underway. Learn more ...

Merck reported positive results from a trial of Winrevair, the heart drug that the company is counting on for much of its ...

A BMW driver who stormed out of his mum’s birthday party after an argument, has ended up writing off the luxury vehicle after ...

As he discussed Amgen, it was unsurprising that weight loss drug giant Eli Lilly and Company (NYSE:LLY) also caught Cramer’s ...

Let’s delve into the details of each of the evaluated factors, but first, for a quick background: With a $917 Bil market cap, ...